6th International Yale Rheumatology Symposium: Future Directions in Lupus

1. Apply evidence-based diagnostic criteria and assessment tools, in collaboration with interprofessional care team members, to accurately diagnose patients with systemic lupus erythematosus (SLE).
2. Implement guideline-concordant, team-based treatment strategies to optimize the management of patients with SLE across disease stages.
3. Evaluate and integrate emerging therapies for SLE into shared, interprofessional clinical decision-making, aligned with the roles and responsibilities of the care team.

Online registration has now been closed in order to prepare materials for the symposium. Please note, walk-in/onsite registration will be accepted the day of the symposium.

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC POINTS
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge Only MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure all accredited activities are developed free from the control of ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) and are balanced, objective and scientifically rigorous. All individuals in a position to control content of an accredited CE activity (such as planners, instructors, authors, course directors, speakers, moderators, reviewers, etc.) are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months. 

Mitigation of Financial Relationships Statement
Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including planners, instructors, authors, course directors, speakers, moderators, reviewers or others are required to disclose all financial relationships with ineligible entities (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of this activity.

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Marie Frank, NA
Senior Administrative Assistant, Section of Rheumatology, Allergy & Immunology
Yale School of Medicine
New Haven, CT

Activity Administrator

Non-Clinical Exception

Richard Bucala, MD, PhD
Waldemar Von Zedtwitz Professor of Medicine, Pathology, and Epidemiology & Public Health
Yale School of Medicine
New Haven, CT

Co-Director, Faculty

Nothing to disclose

Vaidehi Chowdhary, MBBS, MD, DM
Associate Professor; Clinical Chief, Rheumatology, Allergy, & Immunology
Yale School of Medicine
New Haven, CT

Co-Director, Faculty

Nothing to disclose

Robert Schoen, MD, MBA
Clinical Professor of Rheumatology
Yale School of Medicine
Guilford , CT

Course Director, Faculty

Advisor-Pfizer|Speakers Bureau-Abbvie|Speakers Bureau-Amgen|Speakers Bureau-Bristol Myers Squibb (Relationship has ended)|Speakers Bureau-Genentech (Relationship has ended)|Speakers Bureau-Janssen|Speakers Bureau-Lilly (Relationship has ended)|Speakers Bureau-Sanofi|Paid consultant-UCB

Joseph Craft, MD
Paul B. Beeson Professor of Medicine (Rheumatology) and Professor of Immunobiology
Yale School of Medicine
New Haven, CT

Faculty

Nothing to disclose

Shivani Garg, MD, PhD
Associate Professor, Section of Rheumatology, Allergy and Immunology
Yale University
New Haven, CT

Faculty

Nothing to disclose

Peter M Izmirly, MD
Professor, Department of Medicine; Co- Director, NYU Lupus Clinic
NYU Grossman School of Medicine
New York, NY

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-EMD Serono

Diane Kamen, MD, MSCR
Professor of Medicine, Division of Rheumatology
Medical University of South Carolina
Johns Island, SC

Faculty

Paid consultant-AliraHealth

Fotios Koumpouras, MD
Associate Professor of Medicine, Director Yale Lupus Program, Co-Director Rheumatology Dermatology Multidisciplinary Clinic
Yale School of Medicine
New Haven, CT

Faculty

Consulting Fee-Adicet Bio|Speakers Bureau-AstraZeneca

Alfred Lee, MD
Associate Professor of Medicine (Hematology)
Program Director, Hematology/Oncology Fellowship
Yale School of Medicine, New Haven, CT

Faculty

Nothing to disclose

William H Robinson, MD, PhD
Chief, Division of Immunology and Rheumatology
Stanford University
Stanford , CA

Faculty

Consulting Fee-EBVio Inc.|Ownership-Flatiron Bio LLC|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi|Speakers Bureau-Epana Bio|Speakers Bureau-Kernal Bio|Speakers Bureau-Hinge Bio

Brad Rovin, MD
Professor of Medicine
The Ohio State University
Columbus, OH

Faculty

Consulting Fee-Alexion|Grant or research support-AMPEL BioSolutions|Consulting Fee-AstraZeneca|Consulting Fee-Aurinia Pharmaceuticals|Consulting Fee-BioCryst|Consulting Fee-Biogen Idec|Consulting Fee-Bristol Myers Squibb|Grant or research support-ChemoCentryx, Inc.|Consulting Fee-CTI|Consulting Fee-Exagen|Consulting Fee-GlaxoSmithKline|Grant or research support-IQVIA|Consulting Fee-Janssen|Consulting Fee-Kezar Life Sciences|Consulting Fee-Kyverna|Consulting Fee-LuCin|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lupus Foundation of America|Consulting Fee-NephroNet|Consulting Fee-NIH|Consulting Fee-Novartis|Grant or research support-Parexel Intl Corp|Consulting Fee-Pfizer|Consulting Fee-Vera Therapeutics

Georg Schett, MD
Vice President for Research, Professor and Chair of Internal Medicine III
Uniklinikum Erllangen, Germany
Erlangen, Germany

Faculty

Nothing to disclose

Wednesday, May 6, 2026

Thank you to our exhibitors:

• Abbvie

• Alexion

• Amgen

• Argenx

• Arthritis Foundation

• Aurinia

• Bristol Myers Squibb

• Exagen

• Genentech

• GSK

• Johnson&Johnson Innovative Medicine

• Kiniksa Pharmaceuticals

• Kyowa Kirin

• LeoPharma

• Novartis

• Priovant Therapeutics

• Sanofi

• Sobi

• Yale Scleroderma

This CME activity is supported in part by independent medical education grants from:

• Genentech, a member of the Roche Group

• Keenova Therapeutics

• Mylan Inc., a Viatris Company

• Sobi, Inc.

We are grateful for their support!